ReviewCancers2022

Mechanisms of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma.

Stefania De Lorenzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.